Table 1 Summary of infectious disease testing of blood samples used in this study
From: No evidence of bovine leukemia virus proviral DNA and antibodies in human specimens from Japan
Target testing | Method | Result |
|---|---|---|
Hepatitis B surface (HBs) antigen testing | CLEIA | Negative |
Hepatitis B core (HBc) antibody testing | CLEIA | Negative |
HBÂ virus (HBV) DNA nucleic acid testing | PCR | Negative |
Hepatitis C virus (HCV) antibody testing | CLEIA | Negative |
HCV DNA nucleic acid testing | PCR | Negative |
Human immunodeficiency virus type-1, 2 (HIV-1, 2) antibody testing | CLEIA | Negative |
HIV-1, 2 DNA nucleic acid testing | PCR | Negative |
Human T-leukemia virus type 1 (HTLV-I) antibody testing | CLEIA | Negative |
Syphilis treponemal antibody testing | CLEIA | Negative |
Human parvovirus B19 antigen testing | CLEIA | Negative |